ANTIHISTAMINES IN PEDIATRIC PRACTICE



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents data about H1-antihistamines in the treatment of allergic diseases in children.

Full Text

Restricted Access

About the authors

E E VARLAMOV

Research and Clinical Institute for Pediatrics at the Pirogov Russian National Research Medical University

Email: varlamov80@mail.ru
Moscow

A N PAMPURA

Research and Clinical Institute for Pediatrics at the Pirogov Russian National Research Medical University

Moscow

References

  1. Ярилин А.А. Иммунология. ГЭОТАР-Медиа. 2010, с. 752.
  2. Пампура А.Н., Кожевников С.А. Антигистаминные пре- параты в лечении аллергических заболеваний у детей. Вест. педиатр. фармакол. и нутрициол. 2008, № 1, с. 7.
  3. Lewis T., Grant R.T., Marvin H.M. Vascular reactions of the skin to injury. Heart. 1929, v. 14, p. 139-160.
  4. Pampura A.N., Papadopoulos N.G., Špičák V., Kurzawa R. Evidence for Clinical Safety, Efficacy, and Parent and Phy- sician Perceptions of Levocetirizine for the Treatment of Children with Allergic Disease. Int. Arch. Allergy Immunol. 2011, v. 155, p. 367-378.
  5. Sackesen C., Sekerel B.E., Orhan F. et al. The etiology of different forms of urticaria in childhood. Pediatr. Dermatol. 2004, v. 21 (2), p. 102-108.
  6. Mortureux P., Le´aute´-Labre`ze C., Legrain-Lifermann V. et al. Acute urticaria in infancy and early childhood: a prospective study. Arch. Dermatol. 1998, v. 134, p. 319-323.
  7. Simons F.E.R. Prevention of acute urticaria in young children with atopic dermatitis. J. Allergy Clin. Immunol. 2001, v. 107, p. 703-706.
  8. Пампура А.Н., Чусляева А.А., Погомий Н.В., Тренева М.С. Значение псевдоаллергических реакций в клиниче- ской практике. В кн. Функциональные заболевания и со- стояния у детей. Под ред. А.Д. Царегородцева, В.В. Дли- на. М., 2011, с. 249-267.
  9. Kaplan A.P. Clinical practice. Chronic urticaria and angioede- ma. N. Engl. J. Med. 2002, v. 346, p.175-179.
  10. Sheikh A., Broek V.M., Brown S.G.A., Simons F.E.R. H -antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2007, v. 62 (8), p. 830-837.
  11. Starke P.R., Weaver J., Chowdhury B.A. Boxed warning added to promethazine labeling for pediatric use. N. Engl. J. Med. 2005, v. 352, p. 2653.
  12. Textbook of atopic dermatitis. Edited by Reitamo S., Luger A.T., Steinhoff M. Informa healthcare UC London. 2008, p. 269.
  13. Johnson H.H., DeOreo G.A., Lascheid W.P., Mitchell F. Skin histamine levels in chronic atopic dermatitis. J. Invest. Dermatol. 1960, v. 34, p. 237-238.
  14. Juhlin L. Localization and content of histamine in normal and diseased skin. Acta. Derm. Venereol. 1967, v. 47 (6), p. 383-391.
  15. Федоскова Т.Г. Современные принципы диагностики, терапии и профилактики инсектной аллергии. Рус. мед. журн. 2007, № 2, с. 65-73.
  16. Феденко Е.С., Елисютина О.Г., Ильина Н.И. Эффектив- ность и безопасность диметиден малеата в клинической практике. Рос. Аллергол. журн. 2013, № 6, с. 64-68.
  17. Rehn D., Geissier H., Schuster O. Effect time-course of the inhibition of histamine induced skin reactions by orally applied dimethindene maleate. Agents. Actions. 1991, v. 33 (1-2), p. 221-224.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright © Pharmarus Print Media, 2014



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies